Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
1.
J Oral Pathol Med ; 52(5): 431-439, 2023 May.
Article in English | MEDLINE | ID: mdl-36300726

ABSTRACT

BACKGROUND: Electronic cigarettes are increasing in popularity, but there is only little information on their biologic effects on the oral epithelium, the initial site exposed to electronic cigarette smoke. METHODS: We assessed the oral epithelium response to electronic cigarettes by comparing the histology and RNA transcriptome (mRNA and miRNA) of healthy electronic cigarette vapers to nonsmokers. mRNA was assessed based on: (1) genome-wide; (2) genes previously identified as dysregulated in the oral epithelium of electronic cigarette vapers versus nonsmokers; (3) immune and inflammatory-related genes previously identified as dysregulated in the nasal epithelium of electronic cigarette vapers compared to nonsmokers; (4) genes previously identified as dysregulated in the small airway epithelium of nonsmokers following an acute exposure to electronic cigarette; and (5) genes related to the initial steps of COVID-19 infection. In addition, miRNA was assessed genome-wide. Comparisons were performed using analysis of variance, and Benajmini-Hochberg corrected p < 0.05 was considered significant. RESULTS: The histology of the epithelium, lamina propria and basal layer in electronic cigarette vapers appeared normal. Assessment of mRNA and miRNA, based on all gene lists, did not identify any genes significantly modified in the oral epithelium of electronic cigarette vapers in response to electronic cigarette use. CONCLUSION: An average history of 2 years of vaping results in no detectable histologic or transcriptome abnormalities in the buccal mucosa.


Subject(s)
COVID-19 , Electronic Nicotine Delivery Systems , MicroRNAs , Vaping , Humans , Smokers , Vaping/adverse effects , MicroRNAs/genetics
2.
Head Neck Pathol ; 18(1): 4, 2024 Feb 09.
Article in English | MEDLINE | ID: mdl-38334835

ABSTRACT

Dysgenetic polycystic disease, also known just as polycystic disease, is a very rare developmental abnormality affecting the salivary gland duct system. This entity has been reported in only 21 patients previously, although a careful review suggests only 16 patients have histological evidence of the disease. In previously reported cases, this lesion most commonly presents as either an incidental finding or as a swelling affecting the parotid glands bilaterally, or rarely the submandibular glands bilaterally. This case report details the first time dysgenetic polycystic disease is found affecting the minor salivary glands of the tongue in a 55-year-old male. Histochemical and immunohistochemical stains are presented and include positivity for AE1/AE3 and p63, and negativity for progesterone receptor, androgen receptor, mammaglobin, S100 and BRAF V600E. PAS-D and Congo Red highlight special microamyloid spheroliths structures intraluminally.


Subject(s)
Cysts , Salivary Glands, Minor , Male , Humans , Middle Aged , Salivary Glands, Minor/pathology , Cysts/pathology , Parotid Gland/pathology , Submandibular Gland/pathology , Tongue/pathology
3.
Article in English | MEDLINE | ID: mdl-37891119

ABSTRACT

OBJECTIVE: Differential diagnosis between the non-calcifying variant of calcifying epithelial odontogenic tumor (NCLC-CEOT) and amyloid-rich central odontogenic fibroma (AR-COdF) has become a debate, particularly regarding the frequency of CD1a positivity in both entities. This has led to the growing consensus that CD1a-positive staining in AR-NC lesions confirms the diagnosis of AR-COdF. Here, we assess the validity of this consensus. STUDY DESIGN: We collected the data of a case series of histopathologically distinct CEOTs, NCLC-CEOTs, and COdFs and stained them for CD1a and amyloid. Of the 9 CEOTs and NCLC-CEOTs, we diagnosed 4 as classic, 3 as associated with a dentigerous cyst, and 2 as combined CEOT/adenomatoid odontogenic tumors. Of the 9 COdFs, we diagnosed 3 as epithelial poor, 3 as epithelial rich (lacking amyloid), 2 as hyalinized with amyloid, and 1 as hyalinized without amyloid and assessed the staining results. RESULTS: Of the 9 CEOTs and NCLC-CEOTs, 7 stained positively for CD1a, 5 diffusely and 2 focally. Notably, 2 classic NCLC-CEOTs stained strongly CD1a positive. All 3 of the epithelial-poor COdFs were predictably CD1a negative. Of the 6 remaining COdFs, 2 were CD1a positive, 1 hyalinized-with-amyloid COdF diffusely and 1 epithelial-rich-without amyloid focally. CONCLUSIONS: CD1a positivity, which occurs in classic CEOT and NCLC-CEOT, does not help distinguish between NCLC-CEOT and AR-COdF and is inconsistent in all AR-COdFs. The diagnosis of CEOT and AR-COdF should be guided by appropriate histopathologic criteria irrespective of CD1a staining or the presence of amyloid or calcifications.


Subject(s)
Fibroma , Odontogenic Tumors , Skin Neoplasms , Humans , Amyloid , Fibroma/diagnosis , Fibroma/pathology , Odontogenic Tumors/diagnosis , Odontogenic Tumors/pathology , Skin Neoplasms/pathology
4.
Head Neck Pathol ; 18(1): 57, 2024 Jun 25.
Article in English | MEDLINE | ID: mdl-38916759

ABSTRACT

Malakoplakia is a rare inflammatory disorder which typically occurs in immunocompromised patients secondary to impaired bactericidal activity of macrophages. While this entity commonly arises in the genitourinary and gastrointestinal tracts, lesions of the head and neck have been reported only rarely, with oral cavity involvement reported in 3 cases. The most common presentation of head and neck malakoplakia is that of a cutaneous flesh-colored papule or nodule. This case report, however, illustrates the first time malakoplakia is identified affecting the maxilla and maxillary alveolar ridge mucosa. Histochemical and immunohistochemical stains are presented and include positivity for PAS, von Kossa stain, iron stain, and CD68 and negativity for GMS and Gram stains, indicating an inability to demonstrate microbial infection. Thus, clinicians and pathologists alike should be aware of malakoplakia as a pathologic entity when forming differential diagnoses, particularly in immunosuppressed individuals.


Subject(s)
Malacoplakia , Humans , Malacoplakia/pathology , Malacoplakia/diagnosis
5.
Article in English | MEDLINE | ID: mdl-36229369

ABSTRACT

Since the global COVID-19 pandemic, numerous reports have been made regarding oral lesions seen in COVID-19 patients. It remains unclear whether or not these are true manifestations of COVID-19. Here we present 3 patients who were hospitalized for COVID-19 and who developed atypical herpetic ulcerations during their treatment with remdesivir (Veklury) and steroids. In healthy patients, recurrent infection by herpes simplex virus (HSV) presents as lesions only on the lips and the attached oral mucosa. Atypical herpetic ulcerations are seen in immunocompromised patients. They present as large, stellate shaped ulcerations with raised borders and may involve movable mucosa. The 3 cases presented in this report resembled the atypical herpetic ulcerations typically seen in patients with immunosuppression. Through our report, we aimed to introduce the possibility of atypical herpetic ulcers in patients being treated for COVID-19, to allow for their timely diagnosis and to raise awareness of the underlying immunocompromised state.


Subject(s)
COVID-19 , Herpes Simplex , Oral Ulcer , Stomatitis, Herpetic , Humans , Herpes Simplex/diagnosis , Herpes Simplex/pathology , Ulcer , Pandemics , COVID-19/complications , Stomatitis, Herpetic/diagnosis , Stomatitis, Herpetic/drug therapy , Stomatitis, Herpetic/pathology
6.
Article in English | MEDLINE | ID: mdl-37735003

ABSTRACT

OBJECTIVE: We aimed to characterize the histology and the clinicodemographic features of mucoepidermoid carcinoma (MEC), showing continuity with the oral surface mucosa. STUDY DESIGN: We reviewed 138 cases of intraoral MEC to identify cases that showed continuity with the surface mucosa and compared their clinicodemographic findings with those of MECs not showing continuity. We compared the sex ratio using the 2-sample Z-test and compared the age distribution using the 2-sample Kolmogorov-Smirnov test. RESULTS: Of the 138 cases examined, 14 showed continuity with the surface mucosa. Their histology showed surface mucosa with an apparent transition to an infiltrating tumor with mucous, intermediate, and epidermoid tumor cells growing in solid and cystic patterns. Their clinical appearance ranged from firm submucosal nodules to erythematous to ulcerated lesions. They showed a strong female predilection (6:1) and sharply bimodal age distribution, with sharp peaks in the fourth and seventh decades. CONCLUSIONS: Mucoepidermoid carcinomas that show continuity have a demographic pattern distinct from that of conventional MECs, showing a striking female predilection and bimodal age distribution and suggesting a difference in etiology. Pathologists should remain aware that MEC in the oral cavity can have a histologic appearance of surface origin to reach the correct diagnosis.


Subject(s)
Carcinoma, Mucoepidermoid , Salivary Gland Neoplasms , Female , Humans , Carcinoma, Mucoepidermoid/surgery , Mucous Membrane/pathology , Salivary Gland Neoplasms/pathology , Male
7.
Head Neck Pathol ; 9(2): 269-72, 2015 Jun.
Article in English | MEDLINE | ID: mdl-24997629

ABSTRACT

Malignant rhabdoid tumors (MRTs) are exceedingly rare lesions. To our knowledge, only 2 cases have been reported in the oral cavity, with both examples occurring in infants. The current case is the third reported case of MRT of the oral cavity and the first reported case to occur in an adult at this location. The following report describes the clinical, histologic and immunohistochemical features of this tumor.


Subject(s)
Mouth Neoplasms/diagnosis , Mouth Neoplasms/therapy , Mouth/pathology , Rhabdoid Tumor/diagnosis , Rhabdoid Tumor/therapy , Biomarkers, Tumor/metabolism , Combined Modality Therapy , Female , Humans , Middle Aged , Mouth/metabolism , Mouth Neoplasms/pathology , Oral Surgical Procedures , Radiotherapy , Rhabdoid Tumor/pathology , Treatment Outcome , Vimentin/metabolism
8.
Article in English | MEDLINE | ID: mdl-22940020

ABSTRACT

Anaplastic large cell lymphoma (ALCL), a subgroup of T-cell non-Hodgkin's lymphoma, is an uncommon tumor exhibiting CD30 positivity and a characteristic immunophenotypic profile. Histologically, ALCL is characterized by the proliferation of large, anaplastic lymphoid cells with eccentric horseshoe- or kidney-shaped nuclei and one or more prominent nucleoli. Rare cases have been cited in the literature of ALCL presenting primarily in the oral cavity. The purpose of this article was to present 2 instructive cases of CD30+, anaplastic lymphoma kinase-negative ALCL with oral and systemic involvement.


Subject(s)
Lymphoma, Large-Cell, Anaplastic/diagnosis , Mouth Neoplasms/diagnosis , Tongue Neoplasms/diagnosis , Adult , Biopsy , Diagnosis, Differential , Female , Humans , Ki-1 Antigen/metabolism , Lymphoma, Large-Cell, Anaplastic/metabolism , Lymphoma, Large-Cell, Anaplastic/pathology , Magnetic Resonance Imaging , Male , Middle Aged , Mouth Neoplasms/metabolism , Mouth Neoplasms/pathology , Radiography, Thoracic , Tomography, X-Ray Computed , Tongue Neoplasms/metabolism , Tongue Neoplasms/pathology
9.
Am J Dermatopathol ; 25(1): 12-5, 2003 Feb.
Article in English | MEDLINE | ID: mdl-12544093

ABSTRACT

Oral melanoacanthoma (MA) is rare reactive mucosal lesion that, like cutaneous MA, demonstrates hyperplasia of spinous keratinocytes and melanocytes. Unlike MA of the skin, oral MA is unrelated to seborrheic keratosis. This series adds 10 cases to the limited number of previous reports of oral MA. The clinicopathologic features of the cases in this series are generally consistent with those previously reported in the literature; that is, although documented in various intraoral locations in patients of differing ethnicity, oral melanoacanthoma most often presents as an enlarging flat or slightly raised area of hyperpigmentation on the buccal mucosa of adult black women. The current series provides evidence of occurrence over a wider age range (5-77 years) than previously reported. Additionally, the reactivity of oral melanoacanthoma to HMB-45 was investigated. Strong HMB-45 reactivity was present in all cases, thus demonstrating its limited utility in distinguishing oral MA from malignant melanoma.


Subject(s)
Melanoma/pathology , Mouth Neoplasms/pathology , Papilloma/pathology , Skin Neoplasms/pathology , Adult , Aged , Antigens, Neoplasm , Child, Preschool , Female , Humans , Immunoenzyme Techniques , Male , Melanocytes/pathology , Melanoma/chemistry , Melanoma-Specific Antigens , Middle Aged , Mouth Mucosa/pathology , Mouth Neoplasms/chemistry , Neoplasm Proteins/analysis , Papilloma/chemistry , Skin Neoplasms/chemistry
SELECTION OF CITATIONS
SEARCH DETAIL